Unusual Presentation of Denys-Drash Syndrome in a Girl with Undisclosed Consumption of Biotin
PDF

Case Report

Unusual Presentation of Denys-Drash Syndrome in a Girl with Undisclosed Consumption of Biotin

J Clin Res Pediatr Endocrinol 2021;13(3):347-352 DOI: 10.4274/jcrpe.galenos.2020.2020.0064
, , , , , ,
PDF
Permissions

Abstract

We describe a 46,XX girl with Denys-Drash syndrome, showing both kidney disease and genital abnormalities, in whom a misdiagnosis of hyperandrogenism was made. A 15 year-old girl was affected by neonatal nephrotic syndrome, progressing to end stage kidney failure. Hair loss and voice deepening were noted during puberty. Pelvic ultrasound and magnetic resonance imaging showed utero-tubaric agenesis, vaginal atresia and urogenital sinus, with inguinal gonads. Gonadotrophin and estradiol levels were normal, but testosterone was increased up to 285 ng/dL at Tanner stage 3. She underwent prophylactic gonadectomy. Histopathology reported fibrotic ovarian cortex containing numerous follicles in different maturation stages and rudimental remnants of Fallopian tubes. No features of gonadoblastoma were detected. Unexpectedly, testosterone levels were elevated four months after gonadectomy (157 ng/dL). Recent medical history revealed chronic daily comsumption of high dose biotin, as a therapeutic support for hair loss. Laboratory immunoassay instruments used streptavidin-biotin interaction to detect hormones and, in competitive immunoassays, high concentrations of biotin can result in false high results. Total testosterone, measured using liquid chromatography tandem mass spectrometry, was within reference intervals. Similar testosterone levels were detected on repeat immunoassay two weeks after biotin uptake interruption. Discordance between clinical presentation and biochemical results in patients taking biotin, should raise the suspicion of erroneous results. Improved communication among patients, health care providers, and laboratory professionals is required concerning the likelihood of biotin interference with immunoassays

Keywords: Denys-Drash syndrome, testosterone, biotin, disorder of sex development

Read the full text

2 sections · 3 figures · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE. WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumor. Nature 1991;353:431-434.

2

Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437-447.

3

Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 1990;60:509-520.

4

Hastie ND. Wilms’ tumour 1 (WT1) in development, homeostasis and disease. Development 2017;144:2862-2872.

5

Hillen LM, Kamsteeg EJ, Schoots J, Tiebosch AT, Speel EJ, Roemen GM, Peutz-Koostra CJ, Stumpel CT. Refining the diagnosis of congenital nephrotic syndrome on long-term stored tissue: c.1097G>A (p.(Arg366His) WT1 mutation causing denys drash Syndrome. Fetal Pediatr Pathol 2016:112-119. Epub 2016 Feb 16

6

Antonius T, van Bon B, Eggink A, van der Burgt I, Noordam K, van Heijst A. Denys-Drash syndrome and congenital diaphragmatic hernia: another case with the 1097G > A(Arg366His) mutation. Am J Med Genet 2008; 146A:496-499.

7

Cho HY, Lee BS, Kang CH, Kim WH, Ha IS, Cheong HI, Choi Y. Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect. Pediatr Nephrol 2006:1909-1912. Epub 2006 Aug 25

8

Wang H, Li G, Zhang J, Gao F, Li W, Qin Y, Chen ZJ. Novel WT1 missense mutations in han Chinese women with premature ovarian failure. Sci Rep 2015;5:13983.

9

Lee JH, Han KH, Lee H, Kang HG, Moon KC, Shin JI, Hahn H, Park YS, Pai KS, Cho BS, Kim SY, Lee SJ, Ha IS, Choi Y, Cheong HI. Genetic basis of congenital and infantile nephrotic syndromes. Am J Kidney Dis 2011;58:1042-1043.

10

Hoefele J, Kemper MJ, Schoenermarck U, Mueller S, Klein HG, Lemke A. Truncating Wilms Tumor suppressor gene 1 mutation in an xx female with adult-onset focal segmental glomerulosclerosis and streak ovaries: a case report. Nephron 2017;135:72-76. Epub 2016 Oct 5

11

Gomes NL, de Paula LCP, Silva JM, Silva TE, Lerário AM, Nishi MY, Batista RL, Faria Júnior JAD, Moraes D, Costa EMF, Hemesath TP, Guaragna-Filho G, Leite JCL, Carvalho CG, Domenice S, Costa EC, Mendonca BB. A 46,XX testicular disorder of sex development caused by a Wilms’ tumour Factor-1 (WT1) pathogenic variant. Clin Genet 2019;95:172-176. Epub 2018 Oct 28

12

Dharnidharka VR, Ruteshouser EC, Rosen S, Kozakewich H, Harris HW Jr, Herrin JT, Huff V. Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. Pediatr Nephrol 2001;16:227-231.

13

Health C for D and R. Safety Communications - The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Center for Devices and Radiological Health. AVAİLABLE FROM: https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication

14

Stieglitz HM, Korpi-Steiner N, Katzman B, Mersereau JE, Styner M. Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements. J Endocr Soc 2018;2:563-569.

15

Chen M, Zhang L, Cui X, Lin X, Li Y, Wang Y, Wang Y, Qin Y, Chen D, Han C, Zhou B, Huff V, Gao F. Wt1 directs the lineage specification of sertoli and granulosa cells by repressing Sf1 expression. Development 2017;144:44-53. Epub 2016 Nov 25

16

Clevidence BA, Marshall MW and Canary JJ. Biotin levels in plasma and urine of healthy adults consuming physiological doses of biotin. Nutr Res 1988;8:1109-1118.